Duopharma Biotech Bhd.(MY:7148)
RM1.10+0.03 (+2.80%)
MY:7148
Duopharma Biotech Bhd. Revenue
RM1.10
At close:+0.03 (+2.80%)
Duopharma Biotech Bhd. (7148) Revenue
Duopharma Biotech Bhd. Revenue
Duopharma Biotech Bhd. had a revenue of 234.36M in the quarter ending Jun 30, 2026, with -5.46%. This bring the company's revenue in the last twelve months to 929.41M, Increased 1.37%. In the fiscal year ending Dec 31, 2025, Duopharma Biotech Bhd. had annual revenue of 931.69M with 14.50% growth.
- Revenue (ttm)
- 929.41M
- Revenue Growth
- 4.79%
- P/S Ratio
- 1.10
- Revenue/Employee
- MYR 465,613
- Employees
- 2,001
- Market Cap
- MYR 1.03B
Revenue Chart
Duopharma Biotech Bhd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 931.69M | 118.00M | 14.50% |
| Dec 31, 2024 | 813.70M | 108.97M | 15.46% |
| Dec 31, 2023 | 704.73M | 8.01M | 1.15% |
| Dec 31, 2022 | 696.72M | 57.54M | 9.00% |
| Dec 31, 2021 | 639.17M | 69.27M | 12.16% |
| Dec 31, 2020 | 569.90M | -6.56M | -1.14% |
| Dec 31, 2019 | 576.46M | 77.74M | 15.59% |
| Dec 31, 2018 | 498.72M | 30.73M | 6.57% |
| Dec 31, 2017 | 467.99M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.